Eucrates Biomedical Acquisition Corp. Unit

$10.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-1.23%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can watch EUCRU and buy or sell other stocks, options, and ETFs commission-free!

About EUCRU

Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY. The listed name for EUCRU is Eucrates Biomedical Acquisition Corp. Unit.

CEO
Parag Saxena
Employees
Headquarters
New York, New York
Founded
Market Cap
134.77M
Price-Earnings Ratio
Dividend Yield
Average Volume
51.64K
High Today
$10.44
Low Today
$10.25
Open Price
$10.44
Volume
8.21K
52 Week High
$11.17
52 Week Low
$9.91

You May Also Like

PNNT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure